Tonix Pharmaceuticals (TNXP) Insider Trading & Ownership $38.87 -3.15 (-7.50%) As of 01:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tonix Pharmaceuticals (NASDAQ:TNXP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.03%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$86,200.00Number OfInsiders Selling(Last 12 Months)0 Get TNXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Tonix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TNXP Insider Buying and Selling by Quarter Tonix Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2025Seth LedermanCEOBuy4,000$21.55$86,200.00 (Data available from 1/1/2013 forward) TNXP Insider Trading Activity - Frequently Asked Questions Who is on Tonix Pharmaceuticals's Insider Roster? The list of insiders at Tonix Pharmaceuticals includes Seth Lederman. Learn more on insiders at TNXP. What percentage of Tonix Pharmaceuticals stock is owned by insiders? 0.03% of Tonix Pharmaceuticals stock is owned by insiders. Learn more on TNXP's insider holdings. Which Tonix Pharmaceuticals insiders have been buying company stock? The following insider purchased TNXP shares in the last 24 months: Seth Lederman ($86,200.00). How much insider buying is happening at Tonix Pharmaceuticals? Insiders have purchased a total of 4,000 TNXP shares in the last 24 months for a total of $86,200.00 bought. Tonix Pharmaceuticals Key ExecutivesDr. Seth Lederman M.D. (Age 66)Co-Founder, President, CEO & Chairman Compensation: $675kMr. Bradley Saenger CPA (Age 50)CFO & Treasurer Compensation: $640.77kMrs. Jessica Edgar MorrisChief Operating OfficerDr. Gregory M. Sullivan M.D. (Age 58)Chief Medical Officer & Secretary Compensation: $661.44kDr. Herbert W. Harris M.D.Ph.D., Executive Vice President of Translational MedicineMs. Siobhan Fogarty B.Sc.M.Sc., Executive Vice President of Product DevelopmentDr. Darryl Rideout Ph.D.Executive Vice President of Experimental ChemistryDr. Sina Bavari Ph.D.Executive Vice President of Infectious Disease Research & DevelopmentDr. Zeil Rosenberg M.D.M.P.H., Executive Vice President of MedicalMr. Thomas Englese (Age 50)Executive Vice President of Commercial Operations More Insider Trading Tools from MarketBeat Related Companies SNDX Insider Transactions CRMD Insider Transactions QURE Insider Transactions GYRE Insider Transactions ELVN Insider Transactions ZYME Insider Transactions CMRX Insider Transactions CDMO Insider Transactions LENZ Insider Transactions NUVB Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals This page (NASDAQ:TNXP) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
